Xylo Technologies Ltd. - ADR
XYLO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.77M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.77 Million |
|---|---|
| Enterprise Value | $1.88 Million |
| Earnings per Share | $-8.36 |
| Beta | 0.17 |
| Outstanding Shares | 766,975 |
Return
| Return on Equity | -33.51% |
|---|---|
| Return on Assets | -16.05% |
| Return on Invested Capital | -44.41% |
Valuation & Multiples
| P/E Ratio | -0.61 |
|---|---|
| PEG | 0.54 |
| Price to Sales | 0.13 |
| Price to Book Ratio | 0.23 |
| Enterprise Value to Revenue | 0.06 |
| Enterprise Value to EBIT | -0.22 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.65 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Xylo Technologies Ltd.
26 employees
CEO: Liron Carmel
medical device company focused on innovative endoscopic procedures and devices. medigus developed an entire endoscopic system for intraluminal treatment of gerd (gastroesophageal reflux disease), one of the most common chronic diseases i...